Narda Medina

574 total citations
21 papers, 332 citations indexed

About

Narda Medina is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Narda Medina has authored 21 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Infectious Diseases and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Narda Medina's work include Fungal Infections and Studies (16 papers), Antifungal resistance and susceptibility (14 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Narda Medina is often cited by papers focused on Fungal Infections and Studies (16 papers), Antifungal resistance and susceptibility (14 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Narda Medina collaborates with scholars based in Guatemala, United States and Spain. Narda Medina's co-authors include Eduardo Arathoon, Blanca Samayoa, Ana Alastruey‐Izquierdo, Tom Chiller, Juan L. Rodrı́guez-Tudela, David W. Denning, Beatriz L. Gómez, Diego H. Cáceres, Ángela María Tobón and Ángela Restrepo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Narda Medina

20 papers receiving 326 citations

Peers

Countries citing papers authored by Narda Medina

Since Specialization

Citations

This map shows the geographic impact of Narda Medina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narda Medina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narda Medina more than expected).

Fields of papers citing papers by Narda Medina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narda Medina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narda Medina. The network helps show where Narda Medina may publish in the future.

Co-authorship network of co-authors of Narda Medina

This figure shows the co-authorship network connecting the top 25 collaborators of Narda Medina. A scholar is included among the top collaborators of Narda Medina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narda Medina. Narda Medina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maximizing Oil Production in a Brown Field: A Case Study of a Compact Wide-Range ESP Deployment in Ecuador 2025 ·(unknown), N. Vela, (unknown), Narda Medina, (unknown), (unknown), (unknown), (unknown), (unknown), Fernando Gordillo León, (unknown), Luis Aguirre, (unknown), M. A. Hidalgo	0
2	Implementation of a rapid diagnostic assay package for cryptococcosis, histoplasmosis and tuberculosis in people living with HIV in Paraguay 2024 ·BMC Infectious Diseases ·(unknown), (unknown), Omar Sued, Narda Medina, Diego H. Cáceres, (unknown), Alexander Jordan, (unknown), (unknown), (unknown), (unknown), Freddy Pérez	9
3	Artificial intelligence-driven mobile interpretation of a semi-quantitative cryptococcal antigen lateral flow assay 2024 ·IMA Fungus ·David Bermejo-Peláez, Ana Alastruey‐Izquierdo, Narda Medina, (unknown), (unknown), Miguel Luengo-Oroz, Juan L. Rodrı́guez-Tudela	7
4	Clinical characteristics, diagnosis, treatment and outcomes of patients living with HIV and co-infected with tuberculosis and histoplasmosis: a 5-y retrospective case series 2024 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·María Eugenia Castellanos, (unknown), (unknown), Narda Medina, (unknown), Theophilus I. Emeto, Eduardo Arathoon	3
5	Digital Platform for Automatic Qualitative and Quantitative Reading of a Cryptococcal Antigen Point-of-Care Assay Leveraging Smartphones and Artificial Intelligence 2023 ·Journal of Fungi ·David Bermejo-Peláez, Narda Medina, (unknown), (unknown), (unknown), Miguel Luengo-Oroz, Juan L. Rodrı́guez-Tudela, Ana Alastruey‐Izquierdo	15
6	Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives 2023 ·Journal of Fungi ·Dallas J. Smith, Jeremy A.W. Gold, Kaitlin Benedict, Karen Wu, Meghan Lyman, Alexander Jordan, Narda Medina, Shawn R. Lockhart, D. Joseph Sexton, Nancy A. Chow, Brendan R. Jackson, Anastasia P. Litvintseva, Mitsuru Toda, Tom Chiller	17
7	Cost-effectiveness evaluation of routine histoplasmosis screening among people living with advanced HIV disease in Latin America and the Caribbean 2023 ·SHILAP Revista de lepidopterología ·Radha Rajasingham, Narda Medina, (unknown), Diego H. Cáceres, Alexander Jordan, Mathieu Nacher, Diego R. Falci, (unknown), Alessandro C. Pasqualotto, Omar Sued, Tom Chiller, Freddy Pérez	8
8	Diagnostic Mycology Laboratories Should Have a Central Role for the Management of Fungal Disease 2022 ·Journal of Fungi ·Narda Medina, Ana Alastruey‐Izquierdo, (unknown), David W. Denning, Eduardo Arathoon, Juan L. Rodrı́guez-Tudela	7
9	Epidemiology and Mortality of Cryptococcal Disease in Guatemala: Two-Year Results of a Cryptococcal Antigen Screening Program 2022 ·Microorganisms ·Narda Medina, Juan L. Rodrı́guez-Tudela, (unknown), (unknown), (unknown), Eduardo Arathoon, Ana Alastruey‐Izquierdo	4
10	Incidence of Histoplasmosis in a Cohort of People with HIV: From Estimations to Reality 2021 ·Microorganisms ·Narda Medina, Juan L. Rodrı́guez-Tudela, Luis A. Aguirre, (unknown), (unknown), (unknown), (unknown), Eduardo Arathoon, David W. Denning, Ana Alastruey‐Izquierdo	19
11	Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador 2021 ·Mycoses ·(unknown), Blanca Samayoa, Narda Medina, Eduardo Arathoon, (unknown), (unknown), Rolando A. Cedillos, (unknown), Angela A. Cleveland, Tom Chiller, Diego H. Cáceres	10
12	A Rapid Screening Program for Histoplasmosis, Tuberculosis, and Cryptococcosis Reduces Mortality in HIV Patients from Guatemala 2021 ·Journal of Fungi ·Narda Medina, Ana Alastruey‐Izquierdo, (unknown), (unknown), (unknown), (unknown), (unknown), Eduardo Arathoon, David W. Denning, Juan L. Rodrı́guez-Tudela	31
13	Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV 2020 ·AIDS ·Narda Medina, Ana Alastruey‐Izquierdo, (unknown), (unknown), (unknown), Luis A. Aguirre, Blanca Samayoa, Eduardo Arathoon, David W. Denning, Juan L. Rodrı́guez-Tudela	24
14	Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in Aspergillus Species Received within a Surveillance Program on Antifungal Resistance in Spain 2019 ·Antimicrobial Agents and Chemotherapy ·Olga Rivero-Menéndez, (unknown), Narda Medina, J. L. Lucio, Emilia Mellado, Ana Alastruey‐Izquierdo	28
15	Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries 2018 ·Journal of Clinical Microbiology ·Diego H. Cáceres, Blanca Samayoa, Narda Medina, Ángela María Tobón, (unknown), (unknown), Ángela Restrepo, Tom Chiller, Eduardo Arathoon, Beatriz L. Gómez	58
16	Barriers to HIV testing in Guatemala: A Qualitative Study 2017 ·Social medicine ·(unknown), Narda Medina, (unknown), (unknown), Kevin McKenna, Blanca Samayoa, (unknown), Eduardo Arathoon, Matthew Anderson	1
17	Burden of serious fungal infections in Guatemala 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·Narda Medina, Blanca Samayoa, (unknown), David W. Denning, (unknown), (unknown), (unknown), John C. Pérez, Eduardo Arathoon	23
18	High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala 2017 ·American Journal of Tropical Medicine and Hygiene ·Blanca Samayoa, Monika Roy, Angela A. Cleveland, Narda Medina, (unknown), Christina M. Scheel, Beatriz L. Gómez, Tom Chiller, Eduardo Arathoon	49
19	Is Expanded HIV Testing Associated with Earlier HIV Diagnosis? Results from an HIV Clinic in Guatemala City 2016 ·Journal of the International Association of Providers of AIDS Care (JIAPAC) ·(unknown), Narda Medina, Blanca Samayoa, (unknown), (unknown), (unknown), (unknown), Matthew Anderson, Eduardo Arathoon	2
20	Whole genome sequencing identifies circulating Beijing-lineage Mycobacterium tuberculosis strains in Guatemala and an associated urban outbreak 2015 ·Tuberculosis ·Joseph W. Saelens, (unknown), (unknown), Narda Medina, (unknown), (unknown), Raúl Herrera, (unknown), (unknown), Jason E. Stout, Eduardo Arathoon, Blanca Samayoa, David M. Tobin	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact